Share:

Recombinant Interleukin-2 (IL-2)

IL-2 is a growth factor protein stimulating immune cell proliferation, used in immunotherapy for cancer. It qualifies as an unmixed immunological product under HTS 3002.13.00, not in retail forms, matching chapter note for interleukins regulating immunological processes.

Import Duty Rates by Country of Origin

Origin CountryMFN RateCh.99 SurchargesTotal Effective Rate
🇨🇳ChinaFree—Free
🇲🇽MexicoFree—Free
🇨🇦CanadaFree—Free
🇩🇪GermanyFree—Free
🇯🇵JapanFree—Free

More Specific Codes

This product may fall under a more specific subheading:

Alternative Classifications

This product could be classified differently depending on its characteristics or intended use.

3002.12.00Same rate: Free

If classified as other blood fractions

Distinction from blood-derived fractions; biotech interleukins specifically under 3002.13.

3006.92.00Higher: 10% vs Free

If put up as opacifying or diagnostic preparations in measured doses

Heading 3006 covers specific measured-dose diagnostics excluded here.

2937.19.00Same rate: Free

If for non-immunological hormones or peptides

Chapter note specifies immunological peptides/proteins only.

Not sure which classification is right?

Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.

Import Tips & Compliance

• Provide recombinant origin certificates and bioactivity assay results; ensure compliance with biologics import alerts; label clearly as unmixed to avoid dosage-based reclassification

Related Products under HTS 3002.13.00

Unmixed Monoclonal Antibody Bevacizumab

Bevacizumab is a recombinant humanized monoclonal antibody that inhibits vascular endothelial growth factor (VEGF) for use in cancer therapy. It falls under HTS 3002.13.00 as an unmixed immunological product, not put up in measured doses or retail packings, consistent with chapter note definitions for immunological products like monoclonal antibodies directly involved in immunological regulation. Supplied in bulk liquid form for pharmaceutical compounding.

Bulk Interferon Alpha-2a

Interferon Alpha-2a is a cytokine protein used for antiviral and anticancer treatment, produced via recombinant DNA technology. Classified under HTS 3002.13.00 as an unmixed immunological product per chapter notes, supplied in bulk vials without measured doses or retail packaging for further formulation.

Unmixed Tumor Necrosis Factor Alpha (TNF-α)

TNF-α is a cytokine involved in systemic inflammation and immune regulation, supplied in bulk for research and therapeutic development. HTS 3002.13.00 applies to this unmixed immunological product per chapter definitions for TNFs.

Bulk Rituximab Monoclonal Antibody

Rituximab targets CD20 on B-cells for lymphoma and autoimmune treatment, a biotech-produced antibody. As an unmixed product not for retail, it fits HTS 3002.13.00 immunological products definition.

Recombinant Erythropoietin (EPO)

EPO is a glycoprotein hormone stimulating red blood cell production, with immunological regulatory roles. Bulk unmixed form classifies under HTS 3002.13.00 as per immunological product notes.

Unmixed Adalimumab Biosimilar

Adalimumab biosimilar is a TNF inhibitor monoclonal antibody for rheumatoid arthritis. Supplied unmixed in bulk, it meets HTS 3002.13.00 for immunological products.